Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study) Saburo KawaiJun OkamuraThe Cooperative Study Group for Liver Cancer Treatment of Japan Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S1 - S6
Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma Kenji JinnoShosuke MoriwakiYoshio Okada Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S7 - S12
Significance of multidisciplinary therapy for hepatocellular carcinoma Yoshifumi KawaradaTakazumi ImaiRyuji Mizumoto Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S13 - S19
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study) Jun OkamuraSaburo KawaiThe Cooperative Study Group for Liver Cancer Treatment of Japan Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S20 - S24
Treatment of small hepatocellular carcinoma Takashi KumadaSatoshi NakanoHideo Okabe Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S25 - S29
Efficacy of combination treatment — (TAE with adriamycin and ethanol) — for hepatocellular carcinoma Yasunori HasuikeJun OkamuraMasami Sakurai Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S30 - S34
Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma Akio HaradaToshiaki NonamiHiroshi Takagi Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S35 - S37
Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions Morito MondenMasato SakonTakesada Mori Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S38 - S44
Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation Seiji KobayashiYoshiaki NarimatsuMasaharu Tsuchiya Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S45 - S50
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study Takafumi IchidaMasashi KatoHitoshi Asakura Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S51 - S54
Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma Keiichi AoyamaTakashi TsukishiroAkiharu Watanabe Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S55 - S59
Assessment of chemoembolization therapy for primary liver cancer using a stabilized Adriamycin-lipiodol suspension Yuji HoriguchiMadoka ItohYouichi Nagamura Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S60 - S64
Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection Koji IkedaHiroki InoueMasayuki Nakajo Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S65 - S68
Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization Hironobu NakamuraHiromichi OiTakahiro Kozuka Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S69 - S71
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma Norio NakaoHideo UchidaOsamu Ishida Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S72 - S76
Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization Keiji YamamotoManabu MasuzawaKazuya Tamura Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S77 - S81
Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors Ming-Yuh HsiehWen-Yu ChangDing-Kwo Wu Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S82 - S85
Transcatheter arterial chemoembolization for hepatocellular carcinoma Chien-Fang YangYung-Jen Ho Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S86 - S88
Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies Hiraku YodonoTaisuke SasakiShoichi D. Takekawa Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S89 - S92
Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma Kenji NakamuraSumio TakashimaYasuto Onoyama Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S93 - S98
Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system Yasuaki AraiTokiko EndoChoichiro Kido Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S99 - S102
Radiotherapy in the treatment of hepatocellular carcinoma and its metastases Shinn-Cherng ChenShi-Long LianYau-Hui Ho Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S103 - S105
Radiation therapy in patients with unresectable hepatocellular carcinoma Takashi UnoJun ItamiNoboru Arimizu Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S106 - S110
Effects of multimodal treatment and hyperthermia on hepatic tumors Yoshimasa TanakaKeizo YamamotoKenji Nagata Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S111 - S114
Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies Takeki ShiinaShuichi MikuriyaMasanao Tani Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S115 - S118
Phase II trial for combined external radiotherapy and hyperthermia for unresectable hepatoma Byung Soo KimHyun Cheol ChungGwi Eon Kim Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S119 - S127
Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution Yasuhiro YumotoKenji JinnoTakao Tsuji Session III: Poster Session Pages: S128 - S136
Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions Chong-Jin Oon Session III: Poster Session Pages: S137 - S142
Changes in the plasma abnormal prothrombin level following treatment of hepatocellular carcinoma Mitsuo KusanoMasami NakanishiMichio Mito Session III: Poster Session Pages: S146 - S149
Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan Kendo KiyosawaSeiichi Furuta Plenary Session: State of the Art in Liver Cancer Pages: S150 - S156
Liver transplantation for hepatocellular carcinoma: clinical results and future aspects Rudolf PichlmayrArved WeimannBurckhardt Ringe Plenary Session: State of the Art in Liver Cancer Pages: S157 - S161
Liver transplantation in Taiwan: the Chang Gung experience Chao-Long ChenKuei-Liang WangWen-Bin Shieh Plenary Session: State of the Art in Liver Cancer Pages: S162 - S165
